FORWARD CAD IDE Study

Part of paid clinical trials in La Jolla, California.

Sponsor
Shockwave Medical, Inc.
Study ID
NCT06662500
Status
Recruiting

Conditions

  • Coronary Arterial Disease (CAD)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Intravascular Lithotripsy — DEVICE
    The Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave Javelin Coronary Catheter is intended to treat calcified stenosis, including calcified stenoses that are anticipated to exhibit resistance to balloon crossing, full dilatation or subsequent uniform coronary stent expansion.

Study Details

The FORWARD CAD IDE Study is a Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study conducted to assess the safety and effectiveness of the Shockwave Intravascular Lithotripsy (IVL) System with the Javelin Coronary IVL Catheter for the treatment of calcified, stenotic de novo coronary artery lesions prior to stenting.

Key Dates

Start date
Apr 4, 2025
Status verified
Feb 2026
Primary completion
Dec 8, 2025
Completion
Dec 31, 2027

Study Design

Enrollment
408 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Shockwave Javelin Coronary IVL Catheter
    The Shockwave Javelin Coronary IVL Catheter will be used to treat subjects with moderate-to-severely calcified, stenotic de novo coronary artery lesions presenting with stable angina or following stabilization after acute coronary syndrome (ACS) that are suitable for non-emergent percutaneous coronary intervention (PCI).

Primary Outcome Measure

Primary Safety Endpoint - Freedom from MACE within 30 days [ Time Frame: 30 Days ]

Central Contacts

Locations (28)

FacilityCityStateZIPSite coordinators
Scripps HealthLa JollaCalifornia92037
Brendan Neilan
858-824-5249
Matthew Price, M.D. (PRINCIPAL_INVESTIGATOR)
University of California, San FranciscoSan FranciscoCalifornia94143
Kaye Reambonanza
415-514-6147
Yousif Ahmad, PhD (PRINCIPAL_INVESTIGATOR)
South Denver Cardiology Associates, P.CLittletonColorado80120
Rachel Kim
303-703-2053
Cinthia Bateman, MD (PRINCIPAL_INVESTIGATOR)
Hartford HospitalHartfordConnecticut06112
Marianne McCarthy
860-972-1788
Saurabh Joshi, MD (PRINCIPAL_INVESTIGATOR)
Medstar Washington Hospital CenterWashington D.C.District of Columbia20010
Michelle Singh
202-877-2190
Ron Waksman, MD (PRINCIPAL_INVESTIGATOR)
The Cardiac and Vascular InstituteGainesvilleFlorida32605
Marti Roberson
352-244-0208
Matheen Khuddus, MD (PRINCIPAL_INVESTIGATOR)
Emory University HospitalAtlantaGeorgia30322
Farhad Jameel
404-712-7665
William Nicholson, MD (PRINCIPAL_INVESTIGATOR)
Piedmont Heart InstituteAtlantaGeorgia30309
Suzanne Corley
404-605-3118
Prashant Kaul, MD (PRINCIPAL_INVESTIGATOR)
Beth Israel Deaconess Medical CenterBostonMassachusetts02215
Jenifer Kaufman
617-632-8956
Hector Tamez, MD (PRINCIPAL_INVESTIGATOR)
Brigham and Women's HospitalBostonMassachusetts02115
Barbora Zvarova
617-525-5028
Kevin Croce, MD (PRINCIPAL_INVESTIGATOR)
Massachusetts General HospitalBostonMassachusetts02114
Sidney Searles
401-601-8007
Suzanne Baron, MD (PRINCIPAL_INVESTIGATOR)
Minneapolis Heart InstituteMinneapolisMinnesota55407
Opeyemi Akindumila
612-863-3900
Emmanouil Brilakis, MD (PRINCIPAL_INVESTIGATOR)
Columbia University Medical Center/New York Presbyterian HospitalNew YorkNew York10032
Kate Dalton, MS, RD, CCRC
347-514-3366
Margaret McEntegart, M.D. (PRINCIPAL_INVESTIGATOR)
Lenox Hill HospitalNew YorkNew York10075
Sara Velichkovikj
212-434-3802
Michael Kim, MD (PRINCIPAL_INVESTIGATOR)
NYU Langone HealthNew YorkNew York10016
Natalie Massenburg
646-634-6178
Claudia Serrano-Gomez, M.D. (PRINCIPAL_INVESTIGATOR)
St. Francis Hospital & Heart CenterRoslynNew York11576
Elizabeth Haag
516-562-6790
Ziad Ali, M.D. (PRINCIPAL_INVESTIGATOR)
NC Heart and Vascular Research, LLCRaleighNorth Carolina27607
James Pierre-Louis
919-784-8695
James Zidar, MD (PRINCIPAL_INVESTIGATOR)
The Christ HospitalCincinnatiOhio45219
Kiera Carlisle
513-585-1777
Jarrod Frizzel, MD (PRINCIPAL_INVESTIGATOR)
Providence St. VincentPortlandOregon97225
Sheryl Ames
503-216-2099
Jason Wollmuth, MD (PRINCIPAL_INVESTIGATOR)
Wellspan York HospitalYorkPennsylvania17403
Lori Slenker
717-356-5159
Rhian Davies, DO (PRINCIPAL_INVESTIGATOR)
Centennial HeartNashvilleTennessee37203-
Baylor Scott & White Research Institute DallasDallasTexas75226
Geoffrey Gong
214-820-3319
Robert Stoler, MD (PRINCIPAL_INVESTIGATOR)
Houston Methodist HospitalHoustonTexas77030
Padmaja Naik
281-615-9407
Alpesh Shah, MD (PRINCIPAL_INVESTIGATOR)
Baylor Scott and White - The Heart Hospital Baylor PlanoPlanoTexas75093
Selena Ortega
469-814-4738
Srinivasa Potluri, MD (PRINCIPAL_INVESTIGATOR)
Intermountain Medical Center Heart InstituteSalt Lake CityUtah84111
Michael Tomlinson
801-507-4833
Mitul Patel, MD (PRINCIPAL_INVESTIGATOR)
Overlake Medical CenterBellevueWashington98004
Diana Samolyuk
425-899-5419
Robert Riley, MD (PRINCIPAL_INVESTIGATOR)
Swedish MedicalSeattleWashington98122
Tina Pratt
206-320-3919
Christopher Brown, MD (PRINCIPAL_INVESTIGATOR)
University of Washington Medical CenterSeattleWashington98195
John Tushinski
206-685-4346
Lorenzo Azzalini, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in La Jolla, CA

Related Studies